-
EP4196117
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4196117
| EP4196117 - FUNCTIONALIZED PEPTIDES AS ANTIVIRAL AGENTS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 19.05.2023 Database last updated on 15.06.2024 | |
| Former | The international publication has been made Status updated on 21.02.2022 | Most recent event Tooltip | 20.10.2023 | Change: Validation states | published on 22.11.2023 [2023/47] | Applicant(s) | For all designated states Enanta Pharmaceuticals, Inc. 500 Arsenal Street Watertown, MA 02472 / US | [2023/25] | Inventor(s) | 01 /
PANARESE, Joseph D. Newton, MA 02460 / US | 02 /
DAVIS, Dexter Watertown, MA 02472 / US | 03 /
KENTON, Nathaniel Thomas Watertown, MA 02472 / US | 04 /
BARTLETT, Samuel Brighton, MA 02135 / US | 05 /
RAFFERTY, Sean M. Watertown, MA 02472 / US | 06 /
OR, Yat Sun Walthan, MA 02452 / US | [2023/25] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2023/25] | Application number, filing date | 21856680.0 | 12.08.2021 | [2023/25] | WO2021US45632 | Priority number, date | US202063065283P | 13.08.2020 Original published format: US 202063065283 P | [2023/25] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022036018 | Date: | 17.02.2022 | Language: | EN | [2022/07] | Type: | A1 Application with search report | No.: | EP4196117 | Date: | 21.06.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 17.02.2022 takes the place of the publication of the European patent application. | [2023/25] | Search report(s) | International search report - published on: | US | 17.02.2022 | Classification | IPC: | A61K31/4155, A61P31/00, C07D207/27 | [2023/25] | CPC: |
A61P31/14 (EP,IL,KR,US);
C07K5/06156 (EP,IL,KR,US);
C07K5/06139 (EP,IL,KR,US);
A61K38/00 (EP,IL,KR,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/25] | Extension states | BA | 27.02.2023 | ME | 27.02.2023 | Title | German: | FUNKTIONALISIERTE PEPTIDE ALS ANTIVIRALE MITTEL | [2023/25] | English: | FUNCTIONALIZED PEPTIDES AS ANTIVIRAL AGENTS | [2023/25] | French: | PEPTIDES FONCTIONNALISÉS UTILISÉS EN TANT QU'AGENTS ANTIVIRAUX | [2023/25] | Entry into regional phase | 27.02.2023 | National basic fee paid | 27.02.2023 | Search fee paid | 27.02.2023 | Designation fee(s) paid | 27.02.2023 | Examination fee paid | Examination procedure | 27.02.2023 | Examination requested [2023/25] | 28.08.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 05.07.2023 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]US2014243341 (CHANG KYEONG-OK [US], et al) [A] 1-16 * , especially: Fig. 4, Compound 1. *; | [A] - YANG et al., "Synthesis, Crystal Structure, Structure-Activity Relationships, and Antiviral Activity of a Potent SARS Coronavirus 3CL Protease Inhibitor", J. Med. Chem., (20060000), vol. 49, doi:10.1021/jm0603926, pages 4971 - 4980, XP055018993 [A] 1-16 * , especially: pg 4972, Table 1, TG-0205221. * DOI: http://dx.doi.org/10.1021/jm0603926 | [A] - LEE et al., "Structural Basis of Inhibition Specificities of 3C and 3C-like Proteases by Zinc- coordinating and Peptidomimetic Compounds", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (20090000), vol. 284, no. 12, doi:10.1074/jbc.M807947200, pages 7646 - 7655, XP055134941 [A] 1-16 * , especially: pg 7650, Table 2, TG-0205486. * DOI: http://dx.doi.org/10.1074/jbc.M807947200 |